docetaxel anhydrous has been researched along with Leukemia, Myelomonocytic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habuchi, T; Numakura, K; Takahashi, N; Tsuchiya, N | 1 |
1 review(s) available for docetaxel anhydrous and Leukemia, Myelomonocytic, Acute
| Article | Year |
|---|---|
[Therapy related leukemia with 11q23 abnormality induced by chemotherapy consisted of docetaxel for advanced prostatic carcinoma: case report].
Topics: Aged; Antineoplastic Agents; Carcinoma; Chromosomes, Human, Pair 11; Combined Modality Therapy; Docetaxel; Humans; Leukemia, Myelomonocytic, Acute; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Prostatectomy; Prostatic Neoplasms; Taxoids; Translocation, Genetic | 2009 |